7030B-C5 is a PCSK9 inhibitor (IC50=1.61 µM). 7030B-C5 can significantly reduce plasma cholesterol and triglyceride (TG) levels in vivo and slow the progression of atherosclerosis. 7030B-C5 can be used in the study of cardiovascular diseases[1].
Molecular Weight:
359.38
CAS Number:
[370871-42-4]
Formula:
C17H21N5O4
Target:
PCSK9
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted